TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NPCE

Neuropace Inc

Healthcare · Medical Devices · —

14.50$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Neuropace Inc (NPCE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 97 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NPCE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
99 108 99 94 96 95 110 106 107 106 99 97
84 93 84 80 83 81 97 94 95 94 87 86
9.7 18 13 13 15 13 27 23 21 22 15 13
61 66 59 56 57 53 66 62 60 61 54 52
11 12 12 11 12 13 15 14 15 15 15 15
9.8 11 11 11 12 13 14 16 18 17 17 18
83 87 85 85 86 87 86 87 89 87 84 85
13 16 13 13 15 15 15 17 20 18 16 17
1.6 1.6 1.7 1.7 1.8 1.9 1.9 2.0 2.1 2.1 2.2 2.3
1.2 2.3 3.3 2.3 2.2 3.0 4.0 4.7 4.6 2.2 4.5 4.2
56 57 58 59 59 60 60 59 59 59 59 59
16 21 14 9.9 9.8 8.0 24 19 19 19 14 12
-498 -504 -513 -520 -526 -531 -538 -546 -550 -552 -559 -565
26 26 28 29 29 30 31 33 33 33 34 34

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?